CIK 0001544227 · Non-accelerated filer<br>Smaller reporting company
Tempest Therapeutics, Inc.
Sign in to watch- Ticker
- TPST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 451472564
- Phone
- 415-798-8589
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA, 94005
- Former names
- Millendo Therapeutics, Inc., OvaScience, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-26 | Minai-Azary Jennifer Lynn Chief Financial Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2021-02-26 | Arcudi III Louis J President and CEO | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2020-06-22 | Nuechterlein Carole Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-06-22 | HOWE JOHN P MD Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-06-22 | Gallagher Carol Giltner Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-06-22 | Hedley Mary Lynne Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-06-22 | Dable Habib J Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-06-22 | NICHOL GEOFFREY Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-06-22 | Hindman James M. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-05-25 | Arcudi III Louis J Chief Financial Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2020-05-25 | Zeidan Ryan Chief Development Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2020-05-25 | JOSEPH TAMARA L General Counsel and Secretary | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2020-05-25 | Arbet-Engels Christophe Chief Medical Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2020-05-25 | Owens Julia C. President and CEO | Grant or award · Stock Option (right to buy) | +282,000 | 282,000 | ||
| 2020-03-28 | Zeidan Ryan Chief Development Officer | Grant or award · Employee Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-02-10 | Arbet-Engels Christophe Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2020-01-31 | Owens Julia C. President and CEO | Grant or award · Employee Stock Option (right to buy) | +215,000 | 215,000 | ||
| 2020-01-31 | JOSEPH TAMARA L General Counsel and Secretary | Grant or award · Employee Stock Option (right to buy) | +56,250 | 56,250 | ||
| 2020-01-31 | Zeidan Ryan Chief Development Officer | Grant or award · Employee Stock Option (right to buy) | +41,250 | 41,250 |
Page 6 of 6 · 119 trades